Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Clevenger

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
The Chicago Medical Journal and Examiner|August 24, 2023
County Insane Asylum Affairs: The Following Communications Explain Themselves: An Open Letter to the Commissioners of Cook County, IllinoisS V Clevenger
The Chicago Medical Journal and Examiner|August 24, 2023
Report on the Recent Appearances Observed Post-Mortem in a Case of Delirium GraveS V Clevenger
Breast Disease|February 3, 2005
Role of prolactin/prolactin receptor signaling in human breast cancerCharles V Clevenger
The American Journal of Pathology|October 29, 2004
Roles and regulation of stat family transcription factors in human breast cancerCharles V Clevenger
Endocrinology|August 3, 2022
Breast Cancer and Prolactin - New Mechanisms and ModelsCharles V Clevenger, Hallgeir Rui
The Journal of Biological Chemistry|August 5, 2016
Identification of NEK3 Kinase Threonine 165 as a Novel Regulatory Phosphorylation Site That Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell MigrationKatherine M Harrington, Charles V Clevenger
Molecular Endocrinology (Baltimore, Md.)|July 15, 2006
Ligand-independent dimerization of the human prolactin receptor isoforms: functional implicationsSamantha L Gadd, Charles V Clevenger
The Journal of Biological Chemistry|May 5, 2001
Identification and characterization of the prolactin-binding protein in human serum and milkJ B Kline, C V Clevenger
Molecular Endocrinology (Baltimore, Md.)|June 1, 1994
The protein tyrosine kinase P59fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytesC V Clevenger, M V Medaglia
Immunomethods|August 1, 1994
Prolactin as a second messenger for interleukin 2M B Prystowsky, C V Clevenger
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
The Chicago Medical Journal and Examiner|August 24, 2023
County Insane Asylum Affairs: The Following Communications Explain Themselves: An Open Letter to the Commissioners of Cook County, IllinoisS V Clevenger
The Chicago Medical Journal and Examiner|August 24, 2023
Report on the Recent Appearances Observed Post-Mortem in a Case of Delirium GraveS V Clevenger
Breast Disease|February 3, 2005
Role of prolactin/prolactin receptor signaling in human breast cancerCharles V Clevenger
The American Journal of Pathology|October 29, 2004
Roles and regulation of stat family transcription factors in human breast cancerCharles V Clevenger
Endocrinology|August 3, 2022
Breast Cancer and Prolactin - New Mechanisms and ModelsCharles V Clevenger, Hallgeir Rui
The Journal of Biological Chemistry|August 5, 2016
Identification of NEK3 Kinase Threonine 165 as a Novel Regulatory Phosphorylation Site That Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell MigrationKatherine M Harrington, Charles V Clevenger
Molecular Endocrinology (Baltimore, Md.)|July 15, 2006
Ligand-independent dimerization of the human prolactin receptor isoforms: functional implicationsSamantha L Gadd, Charles V Clevenger
The Journal of Biological Chemistry|May 5, 2001
Identification and characterization of the prolactin-binding protein in human serum and milkJ B Kline, C V Clevenger
Molecular Endocrinology (Baltimore, Md.)|June 1, 1994
The protein tyrosine kinase P59fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytesC V Clevenger, M V Medaglia
Immunomethods|August 1, 1994
Prolactin as a second messenger for interleukin 2M B Prystowsky, C V Clevenger
Pageof 12